M S , B. et al. 2022. The Monoclonal Antibody Cocktail in SARS-CoV 2: A Bonanza for Patients With Chronic Lymphocytic Leukemia?. International Journal of Sciences: Basic and Applied Research (IJSBAR). 62, 1 (Apr. 2022), 198–204.